ATRA vs GL · rev $128.9M vs P/E 10, $10.26B cap
Atara Biotherapeutics Inc (ATRA) versus Globe Life Inc (GL) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Globe Life Inc (GL) is a insurance - life company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
GL does not have a complete income-statement cache yet.
ATRA currently screens at market cap $87.1M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Not investment advice. Open the ATRA and GL stock pages for the full models.
Not investment advice.